Marianela buys PAH 22.35: J.P.Morganâs Geoff Meacham Plucks Biotechs with Upside from a Down Market
Weâre a little worried about Unitedâs patent case. There is an ongoing litigation with Novartis AG (NVS:NYSE)/Sandoz for Remodulin (treprostinil) for pulmonary arterial hypertension (PAH). The two primary patents in question are expiring in 2014 and 20 ... ...
39 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home